In a limited set of human trials involving CD19-CAR T cell therapy for SLE, patients who treated with their own engineered T cells showed considerable growth of CAR T cells in their body, rapid improvement in lupus symptoms, and minimal or no side effects [103]. The gene discussed is CD19; the disease is systemic lupus erythematosus.